Comparative biochemistry of human skin: Glycosaminoglycans from different body sites in normal subjects and in patients with localized scleroderma

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 1, 2003, Pages 14-19

  Passos, C O ^a   Werneck, C C ^a   Onofre, G R ^a   Pagani, E A ^a   Filgueira, A L ^a   Silva, L C F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Disaccharides; Glycosaminoglycans; Human skin; Scleroderma

Indexed keywords

CORTICOSTEROID; DERMATAN SULFATE; DISACCHARIDE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; N ACETYLGALACTOSAMINE 4 SULFATASE; PENICILLAMINE; PSORALEN;

ADOLESCENT; ADULT; AGAR GEL ELECTROPHORESIS; ANALYTICAL PARAMETERS; ARTICLE; BIOCHEMISTRY; BODY REGIONS; CASE REPORT; CONTROLLED STUDY; DEPOLYMERIZATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STRUCTURE; PUVA; SCLERODERMA; SKIN BIOPSY;

ADULT; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DERMATAN SULFATE; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; MALE; SCLERODERMA, LOCALIZED; SKIN;

EID: 0037259310     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00576.x     Document Type: Article

References (15)

1. Fleischmajer R, Perlish JS. Glycosaminoglycans in scleroderma and scleredema. J Invest Dermatol 1972; 58: 129-132.
2. Akimoto S, Hayashi H, Ishikawa H. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis. Br J Dermatol 1992; 126: 29-34.
3. Higuchi T, Ohnishi K, Hayashi H, Ishikawa O, Miyachi Y. Changes in skin disaccharide components correlate with the severity of sclerotic skin in systemic sclerosis. Acta Derm Venereol (Stockh) 1994; 74: 179-182.
4. Yokoyama Y, Ishikawa O, Miyachi Y. Disaccharide analysis of skin glycosaminoglycans in localized scleroderma. Dermatology 1997; 194: 329-333.
5. Cardoso LEM, Mourão PAS. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 1994; 14: 115-124.
6. Rocha LAG, Martins RCL, Werneck CC, Feres-Filho EJ, Silva LCF. Human gingival glycosaminoglycans in cyclosporin-induced overgrowth. J Periodont Res 2000; 35: 158-164.
7. Saito N, Yamagata T, Suzuki S. Enzymatic methods for the determination of small quantities of isomeric chondroitin sulfates. J Biol Chem 1968; 243: 1536-1544.
8. Pavao MSG, Aiello KRM, Werneck CC et al. Highly sulfated dermatan sulfates from ascidians. Structure versus anticoagulant activity of these glycosaminoglycans. J Biol Chem 1998; 273: 27848-27857.
9. Koshiishi I, Takenouchi M, Imanari T. Structural characteristics of oversulfated chondroitin/dermatan sulfates in the fibrous lesions of the liver with cirrhosis. Arch Biochem Byophys 1999; 370: 151-155.
10. Engstrom-Laurent A. Changes in hyaluronan concentration in tissues and body fluids in disease states. Ciba Found Symp 1989; 143: 233-240.
11. Freitas JP, Filipe P, Emerit I et al. Hyaluronic acid in progressive systemic sclerosis. Dermatology 1996; 192: 46-49.
12. Sondergaard K, Heickendorff L, Risteli L et al. Increased levels of type I and III collagen and hyaluronan in scleroderma skin. Br J Dermatol 1997; 136: 47-53.
13. Juhlin L, Tengblad A, Ortonne JP, Lacour JP. Hyaluronate in suction blister from patients with scleroderma and various skin disorders. Acta Derm Venereol 1986; 66: 409-513.
14. Haustein UF, Anderegg U. Pathophysiology of scleroderma: an update. J Eur Acad Dermatol Venereol 1998; 11: 1-8.
15. Roden L, Baker JR, Cifonelli JA, Mathews MB. Isolation of onnective tissue polysaccharides. Meth Enzymol 1972; 73: 73-140.